SELLAS Life Sciences Group (SLS) Q1 2026 Earnings

19MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.11
-0.09
-0.07
-0.05

Details

Expected EPS
-0.063333
Actual EPS
-0.05
Surprise EPS
0.01
Surprise Percent
+21.05%

Description

SELLAS Life Sciences Group (SLS) has reported earnings of -0.05 per share for Q1 2026.

0 Comments

Share your thoughts